Juan V. Luciano

Dr. Juan V. Luciano

Department of Clinical & Health Psychology, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain
+2

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2015 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
WHWinfried Häuser
Winfried Häuser
Jacob AblinJacob Ablin
Jacob Ablin
MFMary-Ann Fitzcharles
Mary-Ann Fitzcharles
GLGeoffrey Littlejohn
Geoffrey Littlejohn
Juan V. LucianoJuan V. Luciano
Juan V. Luciano
BWBrian Walitt
Brian Walitt

6 November 2016 in Disability and Rehabilitation
Verified
Journal Article
Closed access
SFStefano Federici
Stefano Federici
MBMarco Bracalenti
Marco Bracalenti
FMFabio Meloni
Fabio Meloni
Juan V. LucianoJuan V. Luciano
Juan V. Luciano
Purpose: This systematic review examines research and practical applications of the World Health Organization Disability Assessment Schedule (WHODAS 2.0) as a basis for establishing specific criteria for evaluating relevant international scientific literature. The aims were to establish the extent of international dissemination and use of WHODAS 2.0 and analyze psychometric research on its various translations and adaptations. In particular, we wanted to highlight which psychometric features have been investigated, focusing on the factor structure, reliability, and validity of this instrument. Method: Following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) methodology, we conducted a search for publications focused on “whodas” using the ProQuest, PubMed, and Google Scholar electronic databases. Results: We identified 810 studies from 94 countries published between 1999 and 2015. WHODAS 2.0 has been translated into 47 languages and dialects and used in 27 areas of research (40% in psychiatry). Conclusions: The growing number of studies indicates increasing interest in the WHODAS 2.0 for assessing individual functioning and disability in different settings and individual health conditions. The WHODAS 2.0 shows strong correlations with several other measures of activity limitations; probably due to the fact that it shares the same disability latent variable with them.

1 October 2018 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
AFAlbert Feliu-Soler
Albert Feliu-Soler
Francisco MontesinosFrancisco Montesinos
Francisco Montesinos
OGOlga Gutiérrez-Martínez
Olga Gutiérrez-Martínez
WSWhitney Scott
Whitney Scott
LMLance M McCracken
Lance M McCracken
Juan V. LucianoJuan V. Luciano
Juan V. Luciano
It is well known that chronic pain is prevalent, complex to manage, and associated with high costs, in health care and society in general. Thanks to advances in new forms of cognitive behavioral therapy (known as third-wave CBT), currently clinicians and researchers have an empirically validated psychological treatment with increasing research support for the treatment of chronic pain. This treatment is called acceptance and commitment therapy (ACT). The main aim of this paper is to provide a narrative review that summarizes and integrates the current state of knowledge of ACT in the management of chronic pain as well as discuss current challenges and opportunities for progress. Based on the psychological flexibility model, ACT extends previous forms of CBT and integrates many CBT-related variables into six core therapeutic processes. ACT is a process-based therapy that fosters openness, awareness, and engagement through a wide range of methods, including exposure-based and experiential methods, metaphors, and values clarification. To our knowledge, there are three published systematic reviews and meta-analyses that support the effectiveness of ACT for chronic pain and many studies focused on specific processes derived from the psychological flexibility model. There is also promising support for the cost-effectiveness of ACT; however, the current evidence is still insufficient to establish firm conclusions about cost-effectiveness and the most efficient means of delivery. Additional well-designed economic evaluations are needed. Other research aims include delineating the neurobiological underpinnings of ACT, refining available outcome and process measures or develop new ones for ACT trials, and meeting the challenge of wide dissemination and implementation in real-world clinical practice.

19 May 2009 in Social Psychiatry and Psychiatric Epidemiology
Verified
Journal Article
Closed access
PDF file
Antoni Serrano BlancoAntoni Serrano Blanco
Antoni Serrano Blanco
DVDiego J Palao Vidal
Diego J Palao Vidal
Juan V. LucianoJuan V. Luciano
Juan V. Luciano
APAlejandra Pinto-Meza
Alejandra Pinto-Meza
LLLeila Lujan-Barroso
Leila Lujan-Barroso
JHJosep M. Haro
Josep M. Haro

1 April 2014 in Pain
Verified
Journal Article
Closed access
Juan V. LucianoJuan V. Luciano
Juan V. Luciano
JGJosé A. Guallar
José A. Guallar
JAJaume Aguado
Jaume Aguado
YLYolanda López-Del-Hoyo
Yolanda López-Del-Hoyo
BOBárbara Oliván-Blázquez
Bárbara Oliván-Blázquez
JGJavier García-Campayo
Javier García-Campayo
In the last decade, there has been burgeoning interest in the effectiveness of third-generation psychological therapies for managing fibromyalgia (FM) symptoms. The present study examined the effectiveness of acceptance and commitment therapy (ACT) on functional status as well as the role of pain acceptance as a mediator of treatment outcomes in FM patients. A total of 156 patients with FM were enrolled at primary health care centers in Zaragoza, Spain. The patients were randomly assigned to a group-based form of ACT (GACT), recommended pharmacological treatment (RPT; pregabalin + duloxetine), or wait list (WL). The primary end point was functional status (measured with the Fibromyalgia Impact Questionnaire, FIQ). Secondary end points included pain catastrophizing, pain acceptance, pain, anxiety, depression, and health-related quality of life. The differences between groups were calculated by linear mixed-effects (intention-to-treat approach) and mediational models through path analyses. Overall, GACT was statistically superior to both RPT and WL immediately after treatment, and improvements were maintained at 6months with medium effect sizes in most cases. Immediately after treatment, the number needed to treat for 20% improvement compared to RPT was 2 (95% confidence interval 1.2-2.0), for 50% improvement 46, and for achieving a status of no worse than mild impaired function (FIQ total score <39) also 46. Unexpectedly, 4 of the 5 tested path analyses did not show a mediation effect. Changes in pain acceptance only mediated the relationship between study condition and health-related quality of life. These findings are discussed in relation to previous psychological research on FM treatment.

1 August 2012 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
BRBaltasar Rodero
Baltasar Rodero
Juan V. LucianoJuan V. Luciano
Juan V. Luciano
Jesús Montero-MarinJesús Montero-Marin
Jesús Montero-Marin
BCBenigno Casanueva
Benigno Casanueva
JPJuan Carlos Palacin
Juan Carlos Palacin
JGJavier García-Campayo
Javier García-Campayo